# Safety, Tolerance and Antiretroviral Activity of Dasatinib: a Pilot Clinical Trial in Patients With Recent HIV-1 Infection

> **NCT05527418** · PHASE2 · RECRUITING · sponsor: **Eva Bonfill** · enrollment: 24 (estimated)

## Conditions studied

- Recent HIV-1 Infection

## Interventions

- **DRUG:** Dasatinib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05527418
- **Lead sponsor:** Eva Bonfill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-26
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05527418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05527418, "Safety, Tolerance and Antiretroviral Activity of Dasatinib: a Pilot Clinical Trial in Patients With Recent HIV-1 Infection". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05527418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*